Biods Consulting
Computational genomics consulting for pharma, biotech and research teams working with human genomic data
Highlights
- New on EvolcAdded 2026-11-04
About Biods Consulting
BIODS Consulting provides computational biology and translational genomics consulting, including analysis of whole-genome, whole-exome and targeted-panel data, variant interpretation, cohort analysis and reproducible workflow development.
It supports pharma, biotechnology companies, research groups and translational medicine teams through scientific consulting, analytical strategy, method development and research collaborations. The company is registered in Surbiton, United Kingdom, and its founder states that he has provided computational biology support since 2010.
Product: Computational biology and genomics analysis, interpretation, workflow development and scientific consulting.
Jobs at Biods Consulting
More biotech & pharma companies
Biointeractions
Develops biocompatible coatings and materials for medical device manufacturers and implant developersNew on EvolcBioleap
Mechanistic modeling for biopharma teams making drug discovery and clinical development decisionsYoung companyNew on EvolcBiomodal
Sequencing kits that read genetic variants and methylation from the same DNA sample for life science researchersNew on EvolcBiorbyt
Life science research reagents and custom products for scientists and research organizations worldwideNew on EvolcBiorelate
Literature-mined cause-and-effect data linking drugs, genes and diseases, for drug discovery and bioinformatics teamsNew on EvolcRemote-friendlyBiorex Diagnostics
In vitro diagnostic tests and reagents for hospitals, clinics, blood banks and research facilitiesNew on Evolc
Website technologies
Tools and platforms detected on this company’s website, grouped by purpose. Dates record when Evolc observed them.
Content management
- SquarespaceHigh confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Website resourcedeclared script/iframe or software asset
Website detection does not establish a paid subscription or company-wide use. Tools loaded after consent or sign-in may be missed. “No longer observed” does not prove the company stopped using a tool.